Meloside A Protects Dermal Papilla Cells from DHT-Induced Damage via Androgen Receptor Modulation

    Hyun Jun Park, Bong Geun Song, Ji Hoon Song, Seung Hee Park, D. H. Wang, HB Kwon, Ji‐Ean Lee
    From the encyclopedia
    Minoxidil →

    An essential vasodilator with some anti-androgenic effects

    Finasteride →

    Frontline, gold standard treatment for combatting androgenic alopecia

    Image
    Studysummary In this laboratory study, Cucumis melo var. makuwa leaf extract significantly reduced DHT-induced apoptosis in human dermal papilla cells by modulating androgen receptor activity and gene expression, suggesting potential as a therapy for androgenetic alopecia.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    The study explores the effects of Meloside A, derived from Cucumis melo var. makuwa leaf extract, on human dermal papilla cells (HDPCs) affected by dihydrotestosterone (DHT), a key factor in androgenetic alopecia (AGA). Meloside A significantly reduced DHT-induced apoptosis in HDPCs by 57.74% at 1000 ppm and inhibited androgen receptor (AR) nuclear translocation and protein expression. It also decreased the expression of genes like IL-6, TGF-β1, and DKK-1, associated with AGA, and reduced reactive oxygen species generation by 45.45% at 100 ppm. These results suggest that Meloside A could be a promising therapeutic agent for AGA by modulating AR activity and gene expression, offering a potential alternative to treatments like minoxidil and finasteride. However, the findings are based on in vitro models, and further research is needed to confirm its efficacy in more complex systems.
    Discuss this study in the Community →

    Research cited in this study

    23 / 23 results